Cybin Inc. (OTCMKTS:CLXPF – Get Free Report)’s share price rose 1.2% during trading on Thursday . The stock traded as high as $8.3811 and last traded at $8.28. Approximately 717,701 shares were traded during mid-day trading, an increase of 30% from the average daily volume of 551,962 shares. The stock had previously closed at $8.18.
Cybin Stock Up 1.2%
The firm has a market capitalization of $1.23 billion and a PE ratio of -59.14. The stock has a 50-day simple moving average of $8.29 and a 200-day simple moving average of $7.04.
Cybin Company Profile
Cybin Inc (OTCMKTS: CLXPF) is a biotechnology company focused on the research, development and commercialization of psychedelic-based therapeutics for the treatment of mental health and wellness disorders. The company leverages proprietary drug discovery platforms to design novel analogues of psilocybin and other psychoactive compounds. Its programs aim to improve the safety, bioavailability and manufacturability of these molecules while addressing conditions such as depression, anxiety and substance use disorders.
Cybin’s pipeline encompasses several clinical and preclinical stage candidates.
Further Reading
- Five stocks we like better than Cybin
- Silver Is the New Oil—And the World’s Running Dry
- BNZI stands out as a Zacks Buy. Earnings momentum and analyst upgrades align
- What happened in Cyprus could be coming here
- Elon Musk’s $1 Quadrillion AI IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Receive News & Ratings for Cybin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cybin and related companies with MarketBeat.com's FREE daily email newsletter.
